Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Bond Issue

11 Jun 2025 09:37

RNS Number : 3871M
Experian plc
11 June 2025
Β 

Β 

Experian plc

Β 

Β 

Bond Issue

Β 

Β 

11 June 2025 - Experian plc, the global data and technology company, announces that its subsidiary, Experian Finance plc, rated A3 / A-, has priced an issue of $500million 5.250% bonds due 17 August 2035 (the "Notes"). The Notes will be issued by Experian Finance plc and guaranteed byΒ Experian plc.

Β 

This bond issue extends the maturity of the Group's debt portfolio and diversifies its funding sources. The net proceeds of the offering will be used for general corporate purposes, including potential acquisitions and the repayment of debt. The issue is scheduled to close on 17 June 2025, subject to customary conditions.

Β 

It is expected that the Notes will be admitted to the official list of Euronext Dublin and admitted to trading on the Global Exchange Market.

Β 

The Notes are being sold to qualified institutional buyers in the United States in accordance with Rule 144A under the US Securities Act of 1933Β ("Securities Act"), and to non-US persons outside the United States in reliance upon Regulation S under the Securities Act. The Notes and the guarantee have not been, and will not be, registered under the Securities Act, or the securities laws of any state of the United States or other jurisdiction, and may not be offered or sold in the United Sates, or to, or for the account or benefit of, US persons, other than pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

Β 

This announcement does not constitute or form part of any offer or any solicitation to purchase nor shall it, or the fact of its distribution, form the basis of, or be relied on in any purchase. The distribution of this announcement and any subsequent offer of securities may be restricted by law in certain jurisdictions and persons receiving this announcement or any subsequent offer should inform themselves about and observe any such restriction. Failure to comply with such restrictions may violate securities laws of any such jurisdiction.

Β 

Β 

Contact:

Β 

Experian

Remco de Vries Group Treasurer +353 (0) 86 380 2791

Lorraine Keogh Deputy Group Treasurer +353 (0) 86 380 2193

Β 

Β 

About Experian

Β 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

Β 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

Β 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IODSFISAFEISEDM
Date   Source Headline
9th Jun 20264:30 pmRNSDirector/PDMR Shareholding
8th Jun 20263:30 pmRNSDirector/PDMR Shareholding
5th Jun 202611:00 amRNSElections for Second Interim Dividend
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:15 pmRNSNotification of issuance of equity securities
29th May 20265:00 pmRNSTotal Voting Rights
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 202611:45 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSFull-year financial report
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 202610:45 amRNSDirector Declaration
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20265:38 pmRNSNotification of issuance of equity securities
30th Apr 20265:14 pmRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSChair appointment
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20261:15 pmRNSShare repurchase programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.